Novo Nordisk UK in agreement with the Medicines and Healthcare products Regulatory Agency (MHRA) and the Department of Health and Social Care (DHSC) would like to inform you of the following: • An update on the supply shortage for Tresiba FlexTouch 100 U/mL solution for injection • The potential for inappropriate dosing of insulin when switching Tresiba products